LYRA - Lyra Therapeutics, Inc.
IEX Last Trade
0.1924
0.003 1.559%
Share volume: 21,674
Last Updated: Fri 27 Dec 2024 08:22:21 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$0.19
0.00
1.58%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-11-02 | 2022-11-08 | 2023-03-29 | 2023-05-12 | 2023-08-08 | 2023-11-07 | 2024-03-22 | 2024-04-30 | |
| Total revenue | 525.000 K | 359.000 K | 11.000 K | 410.000 K | 458.000 K | 544.000 K | 146.000 K | 532.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 525.000 K | 359.000 K | 11.000 K | 410.000 K | 458.000 K | 544.000 K | 146.000 K | 532.000 K | |
| -31.62% | -96.94% | 3,627.27% | 11.71% | 18.78% | -73.16% | 264.38% | |||
| Operating expenses | 14.925 M | 15.185 M | 13.850 M | 17.723 M | 15.369 M | 17.371 M | 16.623 M | 24.056 M | |
| Selling general and admin | 4.132 M | 5.137 M | 4.399 M | 5.127 M | 4.570 M | 5.003 M | 4.357 M | 5.818 M | |
| Research and development | 10.793 M | 10.048 M | 9.451 M | 12.596 M | 10.799 M | 12.368 M | 12.266 M | 18.238 M | |
| Total expenses | 14.925 M | 15.185 M | 13.850 M | 17.723 M | 15.369 M | 17.371 M | 16.623 M | 24.056 M | |
| 1.74% | -8.79% | 27.96% | -13.28% | 13.03% | -4.31% | 44.72% | |||
| Operating income | -14.400 M | -14.826 M | -13.839 M | -17.313 M | -14.911 M | -16.827 M | -16.477 M | -23.524 M | |
| Ebit | -14.400 M | -14.826 M | -13.839 M | -17.313 M | -14.911 M | -16.827 M | -16.477 M | -23.524 M | |
| Pretax income | -14.366 M | -14.766 M | -14.222 M | -16.241 M | -15.606 M | -15.635 M | -15.139 M | -22.438 M | |
| 2.78% | -3.68% | 14.20% | -3.91% | 0.19% | -3.17% | 48.21% | |||
| Income tax | 0.000 | 0.000 | 13.000 K | 14.000 K | 12.000 K | 16.000 K | 17.000 K | 14.000 K | |
| Net income basic | -14.366 M | -14.766 M | -14.235 M | -16.255 M | -15.618 M | -15.651 M | -15.156 M | -22.452 M | |
| -2.78% | 3.60% | -14.19% | 3.92% | -0.21% | 3.16% | -48.14% | |||
| Net income | -14.366 M | -14.766 M | -14.235 M | -16.255 M | -15.618 M | -15.651 M | -15.156 M | -22.452 M | |
| -2.78% | 3.60% | -14.19% | 3.92% | -0.21% | 3.16% | -48.14% |